Filing Details

Accession Number:
0001493152-20-018750
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-01 21:25:50
Reporting Period:
2020-06-11
Accepted Time:
2020-10-01 21:25:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1661053 Hancock Jaffe Laboratories Inc. HJLI Surgical & Medical Instruments & Apparatus (3841) 330936180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1730174 Biodyne Holding, S.a. 13 Rue De La Gare
Morges V8 1110
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-11 100,000 $0.39 3,255,433 No 4 S Direct
Common Stock Disposition 2020-06-15 100,000 $0.42 3,155,433 No 4 S Direct
Common Stock Disposition 2020-06-16 150,000 $0.43 3,005,433 No 4 S Direct
Common Stock Disposition 2020-06-17 203,100 $0.48 2,802,333 No 4 S Direct
Common Stock Disposition 2020-06-18 61,640 $0.45 2,740,693 No 4 S Direct
Common Stock Disposition 2020-06-19 80,000 $0.46 2,660,693 No 4 S Direct
Common Stock Disposition 2020-06-22 63,186 $0.46 2,597,507 No 4 S Direct
Common Stock Disposition 2020-06-23 80,000 $0.43 2,517,507 No 4 S Direct
Common Stock Disposition 2020-06-24 55,530 $0.42 2,461,977 No 4 S Direct
Common Stock Disposition 2020-06-25 100,000 $0.40 2,361,977 No 4 S Direct
Common Stock Disposition 2020-06-26 80,000 $0.38 2,281,977 No 4 S Direct
Common Stock Disposition 2020-06-29 68,094 $0.39 2,213,883 No 4 S Direct
Common Stock Disposition 2020-07-01 45,000 $0.38 2,168,883 No 4 S Direct
Common Stock Disposition 2020-07-02 57,000 $0.40 2,111,883 No 4 S Direct
Common Stock Disposition 2020-07-06 6,450 $0.39 2,105,433 No 4 S Direct
Common Stock Disposition 2020-07-16 50,000 $0.38 2,055,433 No 4 S Direct
Common Stock Disposition 2020-07-17 50,000 $0.38 2,005,433 No 4 S Direct
Common Stock Disposition 2020-07-20 150,000 $0.43 1,855,433 No 4 S Direct
Common Stock Disposition 2020-07-21 50,000 $0.45 1,805,433 No 4 S Direct
Common Stock Disposition 2020-07-30 25,000 $0.32 1,780,433 No 4 S Direct
Common Stock Disposition 2020-07-31 5,000 $0.34 1,775,433 No 4 S Direct
Common Stock Disposition 2020-08-03 70,000 $0.32 1,705,433 No 4 S Direct
Common Stock Disposition 2020-08-14 50,000 $0.31 1,655,433 No 4 S Direct
Common Stock Disposition 2020-08-18 50,000 $0.34 1,605,433 No 4 S Direct
Common Stock Disposition 2020-08-19 50,000 $0.30 1,555,433 No 4 S Direct
Common Stock Disposition 2020-08-20 75,000 $0.27 1,480,433 No 4 S Direct
Common Stock Disposition 2020-08-21 75,000 $0.38 1,405,433 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. 1,950,000 is the total number of shares sold and these shares were sold in multiple transactions at an average price of $0.38. The reporting person undertakes to provide to Hancock Laboratories Jaffe, Inc., any security holder of Hancock Jaffe Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate transaction at the price set forth in footnote (1) to this Form 4.